Energenesis Biomedical CoTPE:6657 64 Days Inventory is 98.29 as of Dec. 2025, which is 25% below its 10-year median of 130.34. GuruFocus rates TPE:6657 with a GF Score™ of 64/100 and a GF Value™ of NT$51.42 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Energenesis Biomedical Co ranks better than 54.08% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Energenesis Biomedical Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Energenesis Biomedical Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.30.
Energenesis Biomedical Co (TPE:6657) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Energenesis Biomedical Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Energenesis Biomedical Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Energenesis Biomedical Co Days Inventory Related Terms
Energenesis Biomedical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6657 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Energenesis Biomedical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Energenesis Biomedical Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Energenesis Biomedical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Energenesis Biomedical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Energenesis Biomedical Co (TPE:6657) has a Days Inventory of 98.29 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Energenesis Biomedical Co and its competitors. This is 25% below median its historical median of 130.34. Over the past decade, Energenesis Biomedical Co's Days Inventory has ranged from 66.90 to 220.75. According to the industry distribution chart, Energenesis Biomedical Co ranks #293 out of 638 companies in the Biotechnology industry, placing it in the top 45.9%.
Is Energenesis Biomedical Co's Days Inventory too high?
Energenesis Biomedical Co's current Days Inventory of 98.29 is 25% below median its 10-year median of 130.34. Over the past 10 years, this metric has ranged from a low of 66.90 to a high of 220.75. The Biotechnology industry median Days Inventory is 183.20. Energenesis Biomedical Co's value of 98.29 is 46.3% below this industry median. Based on the distribution chart, Energenesis Biomedical Co ranks #293 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Energenesis Biomedical Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Energenesis Biomedical Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Energenesis Biomedical Co ranks #293 out of 638 companies for Days Inventory. This puts Energenesis Biomedical Co in the upper half of its industry. The industry median Days Inventory is 183.20. Energenesis Biomedical Co's value of 98.29 is 46.3% below this benchmark. Historically, Energenesis Biomedical Co's own Days Inventory has ranged from 66.90 to 220.75 over the past decade. While the company's 10-year median is 130.34 vs. the industry median of 183.20, Energenesis Biomedical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Energenesis Biomedical Co's current Days Inventory of 98.29 is 46.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Energenesis Biomedical Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Energenesis Biomedical Co's current Days Inventory is 98.29, which is 25% below median its own 10-year median of 130.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Energenesis Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Energenesis Biomedical Co (TPE:6657) is currently considered Possible Value Trap. The stock's GF Value™ is NT$51.42, compared to a current price of NT$35.30 — trading 31.3% below its estimated fair value. The current Days Inventory is 98.29, which is 25% below median its 10-year median of 130.34 and 46.3% below the Biotechnology industry median of 183.20. Energenesis Biomedical Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Energenesis Biomedical Co (TPE:6657), the current Days Inventory is 98.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Energenesis Biomedical Co (TPE:6657) Overvalued in 2026?
Based on GuruFocus' analysis, Energenesis Biomedical Co stock appears to be undervalued.
The current stock price of NT$35.30 is trading 31.3% below its estimated GF Value™ of NT$51.42.
GuruFocus considers Energenesis Biomedical Co to be Possible Value Trap.
Key valuation signals for TPE:6657:
Days Inventory: 98.29 (25% below median its 10-year median of 130.34)
GF Value™: NT$51.42 vs. price of NT$35.30 (31.3% below fair value)
Industry Position: 46.3% below the Biotechnology median (#293 of 638)
No single metric tells the full story. See the TPE:6657 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Energenesis Biomedical Co Ltd is a biomedicine company. The company is engaged in businesses related to biological experimentation and analysis, as well as new drugs development. The company uses its ENERGI drug development platform to activate AMP-activated protein kinase (AMPK), a key enzyme in cell energy regulation, as a means of developing disease treatments. The product pipeline of the company consists of ENERGI-F703, a diabetic foot ulcers treatment gel; ENERGI-F701, a product developed for male hair loss; ENERGI-F704, an inflammatory bowel disease treatment; and ENERGI-F711, a burn cream,F708, Asthama treatment, and others.
64GF Score
Get the complete analysis for TPE:6657
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6657 has been successfully added to your 
